Literature DB >> 380615

A comparison of the clinical and psychological effects of diazepam and amylobarbitone in anxious patients.

C Z Tansella, M Tansella, M Lader.   

Abstract

1. Twenty-four anxious inpatients were treated with diazepam, amylobarbitone sodium and placebo in flexible dosage for 1 week. They each received all three treatments according to a fully-balanced design, using double-blind procedures. 2. The clinical and the psychological effects of the drugs were assessed by the comprehensive battery of psychiatrist's ratings, subjective and psychological tests before treatment and at the end of each week of treatment. The tests included self-rating of anxiolytic and hypnotic effects, reaction-time, card sorting, coding and cancellation tasks, arithmetic and tappin. 3. Diazepam improved significantly subjective anxiety and insomnia, while amylobarbitone improved only the self-rated quality of sleep. Occasion effects were absent on clinical measures, indicating that the patients did not respond to non-specific temporal factors. Performance on motor tasks improved over time because of the expected practice effect, but an impairment relative to placebo was detected on two motor tests after the barbiturate and on four other tests with a cognitive component after the benzodiazepine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 380615      PMCID: PMC1429679          DOI: 10.1111/j.1365-2125.1979.tb04650.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  24 in total

1.  Residual effects of flunitrazepam.

Authors:  A J Bond; M H Lader
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

2.  [MOGADON, A NEW HYPNOTIC].

Authors:  S WYSS; A MAEDER
Journal:  Schweiz Med Wochenschr       Date:  1965-03-06

3.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

4.  A comparison of hypnotic agents.

Authors:  L LASAGNA
Journal:  J Pharmacol Exp Ther       Date:  1954-05       Impact factor: 4.030

5.  A personality scale of manifest anxiety.

Authors:  J A TAYLOR
Journal:  J Abnorm Psychol       Date:  1953-04

6.  Modification by diazepam or thioridazine of the psychomotor skills related to driving: a subacute trial in neurotic out-patients.

Authors:  I Saario; M Linnoila; M J Mattila
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

7.  A clinical and psychometric evaluation of flurazepam.

Authors:  M R Salkind; T Silverstone
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

8.  Medazepam and the driving ability of anxious patients.

Authors:  N C Moore
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

9.  The effects of chlordesmethyldiazepam on behavioral performance and subjective judgment in normal subjects.

Authors:  C Zimmermann-Tansella; M Tansella; M Lader
Journal:  J Clin Pharmacol       Date:  1976-10       Impact factor: 3.126

10.  Plasma concentrations of diazepam, noradiazepam and amylobarbitone after short-term treatment of anxious patients.

Authors:  M Tansella; C Zimmermann Tansella; L Ferrario; L Preziati; G Tognoni; M Lader
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1978-03
View more
  3 in total

1.  Psychological performance of workers with blood-lead concentration below the current threshold limit value.

Authors:  P Campara; F D'Andrea; R Micciolo; C Savonitto; M Tansella; C Zimmermann-Tansella
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015

2.  Sleep studies in clinical pharmacology.

Authors:  I Oswald
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

3.  Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care.

Authors:  Joseph A Lieberman
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.